Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Telemedicine | 29 | 2024 | 2872 | 2.750 |
Why?
|
Substance-Related Disorders | 25 | 2023 | 4258 | 2.100 |
Why?
|
Mental Disorders | 25 | 2024 | 6600 | 2.030 |
Why?
|
Mental Health Services | 20 | 2021 | 1643 | 1.920 |
Why?
|
Opioid-Related Disorders | 14 | 2023 | 2065 | 1.810 |
Why?
|
Bipolar Disorder | 21 | 2023 | 5027 | 1.610 |
Why?
|
Buprenorphine | 7 | 2023 | 640 | 1.510 |
Why?
|
Alcoholism | 5 | 2023 | 1906 | 1.390 |
Why?
|
Deductibles and Coinsurance | 11 | 2023 | 316 | 1.250 |
Why?
|
Health Benefit Plans, Employee | 6 | 2023 | 332 | 1.100 |
Why?
|
Hospitals, Psychiatric | 3 | 2021 | 332 | 1.090 |
Why?
|
Medicare | 20 | 2024 | 6566 | 1.060 |
Why?
|
Fee-for-Service Plans | 4 | 2022 | 694 | 0.940 |
Why?
|
Psychiatry | 9 | 2022 | 1695 | 0.910 |
Why?
|
Health Expenditures | 14 | 2023 | 2348 | 0.910 |
Why?
|
Patient Isolation | 2 | 2020 | 100 | 0.900 |
Why?
|
Antimanic Agents | 5 | 2014 | 522 | 0.890 |
Why?
|
Restraint, Physical | 2 | 2020 | 193 | 0.840 |
Why?
|
Opiate Substitution Treatment | 5 | 2023 | 404 | 0.770 |
Why?
|
Ambulatory Care | 8 | 2023 | 2708 | 0.750 |
Why?
|
Psychiatric Department, Hospital | 1 | 2020 | 135 | 0.720 |
Why?
|
Medicaid | 14 | 2021 | 2736 | 0.720 |
Why?
|
Pandemics | 17 | 2024 | 8388 | 0.700 |
Why?
|
Mental Health | 10 | 2024 | 3019 | 0.690 |
Why?
|
Healthcare Disparities | 5 | 2020 | 3158 | 0.670 |
Why?
|
Antipsychotic Agents | 10 | 2023 | 3057 | 0.660 |
Why?
|
United States | 63 | 2024 | 69872 | 0.650 |
Why?
|
Quality of Health Care | 8 | 2012 | 4371 | 0.620 |
Why?
|
Alcohol-Related Disorders | 1 | 2020 | 234 | 0.620 |
Why?
|
Insurance Coverage | 10 | 2022 | 1901 | 0.590 |
Why?
|
Office Visits | 1 | 2020 | 598 | 0.550 |
Why?
|
Antidepressive Agents | 9 | 2017 | 2838 | 0.550 |
Why?
|
Rural Population | 6 | 2021 | 2210 | 0.510 |
Why?
|
Schizophrenia | 8 | 2020 | 6882 | 0.490 |
Why?
|
Electroconvulsive Therapy | 1 | 2019 | 477 | 0.480 |
Why?
|
Medication Adherence | 5 | 2017 | 2063 | 0.470 |
Why?
|
Medical Informatics | 1 | 2021 | 745 | 0.470 |
Why?
|
Patient Readmission | 3 | 2020 | 3114 | 0.460 |
Why?
|
Confidentiality | 1 | 2018 | 612 | 0.460 |
Why?
|
Case Management | 1 | 2015 | 286 | 0.460 |
Why?
|
Health Services Accessibility | 7 | 2022 | 5137 | 0.460 |
Why?
|
Government Regulation | 1 | 2018 | 522 | 0.460 |
Why?
|
Research Subjects | 1 | 2015 | 239 | 0.460 |
Why?
|
Aftercare | 4 | 2023 | 866 | 0.450 |
Why?
|
Adjustment Disorders | 1 | 2013 | 70 | 0.440 |
Why?
|
Diffusion of Innovation | 1 | 2018 | 725 | 0.440 |
Why?
|
Electronic Health Records | 4 | 2021 | 4468 | 0.440 |
Why?
|
Inpatients | 5 | 2022 | 2518 | 0.400 |
Why?
|
Humans | 113 | 2024 | 744343 | 0.400 |
Why?
|
Borderline Personality Disorder | 1 | 2019 | 736 | 0.400 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2022 | 9959 | 0.390 |
Why?
|
Outpatients | 5 | 2021 | 1486 | 0.390 |
Why?
|
Electronics | 3 | 2022 | 322 | 0.380 |
Why?
|
Substance Abuse Treatment Centers | 3 | 2020 | 168 | 0.370 |
Why?
|
Managed Care Programs | 5 | 2013 | 950 | 0.370 |
Why?
|
Commitment of Mentally Ill | 1 | 2010 | 94 | 0.370 |
Why?
|
Psychotherapy | 6 | 2020 | 1643 | 0.370 |
Why?
|
Health Services | 1 | 2015 | 758 | 0.360 |
Why?
|
Mentally Ill Persons | 1 | 2010 | 126 | 0.360 |
Why?
|
Adult | 50 | 2023 | 214055 | 0.360 |
Why?
|
Nurse Practitioners | 2 | 2022 | 270 | 0.330 |
Why?
|
Adolescent | 26 | 2023 | 85781 | 0.330 |
Why?
|
Patient Compliance | 2 | 2010 | 2684 | 0.320 |
Why?
|
Insurance Claim Review | 4 | 2020 | 720 | 0.320 |
Why?
|
Insurance, Health | 8 | 2021 | 2494 | 0.310 |
Why?
|
Child Custody | 1 | 2007 | 20 | 0.310 |
Why?
|
Depressive Disorder | 3 | 2017 | 3748 | 0.300 |
Why?
|
Patient Acceptance of Health Care | 5 | 2023 | 3022 | 0.300 |
Why?
|
Young Adult | 22 | 2022 | 56430 | 0.300 |
Why?
|
Patient Selection | 3 | 2015 | 4215 | 0.290 |
Why?
|
Middle Aged | 40 | 2023 | 213383 | 0.280 |
Why?
|
Diagnosis, Dual (Psychiatry) | 2 | 2018 | 295 | 0.280 |
Why?
|
Male | 51 | 2023 | 350118 | 0.280 |
Why?
|
Patient Participation | 1 | 2015 | 1457 | 0.280 |
Why?
|
Community Mental Health Services | 2 | 2011 | 386 | 0.270 |
Why?
|
Medicare Part D | 3 | 2016 | 328 | 0.270 |
Why?
|
Female | 54 | 2023 | 380194 | 0.260 |
Why?
|
Biochemical Phenomena | 1 | 2024 | 59 | 0.240 |
Why?
|
Depressive Disorder, Major | 3 | 2013 | 4644 | 0.230 |
Why?
|
Naltrexone | 2 | 2023 | 307 | 0.230 |
Why?
|
Organizational Innovation | 1 | 2007 | 559 | 0.230 |
Why?
|
Drug Prescriptions | 3 | 2022 | 1637 | 0.230 |
Why?
|
Disulfiram | 1 | 2022 | 57 | 0.220 |
Why?
|
Advanced Practice Nursing | 1 | 2022 | 18 | 0.210 |
Why?
|
Assisted Living Facilities | 1 | 2022 | 25 | 0.210 |
Why?
|
Models, Psychological | 2 | 2020 | 811 | 0.210 |
Why?
|
Attitude | 1 | 2007 | 776 | 0.210 |
Why?
|
Cohort Studies | 14 | 2023 | 40561 | 0.200 |
Why?
|
Ownership | 2 | 2021 | 332 | 0.200 |
Why?
|
Methadone | 1 | 2023 | 306 | 0.190 |
Why?
|
Patients | 1 | 2007 | 900 | 0.190 |
Why?
|
Aged | 24 | 2024 | 163280 | 0.180 |
Why?
|
Health Services Research | 2 | 2014 | 1836 | 0.180 |
Why?
|
Analgesics, Opioid | 5 | 2023 | 3674 | 0.180 |
Why?
|
Narcotic Antagonists | 2 | 2022 | 562 | 0.170 |
Why?
|
Patient Admission | 1 | 2007 | 1380 | 0.170 |
Why?
|
Quality Indicators, Health Care | 4 | 2011 | 1831 | 0.170 |
Why?
|
Comorbidity | 4 | 2019 | 10388 | 0.170 |
Why?
|
Drug Utilization | 5 | 2020 | 1183 | 0.160 |
Why?
|
Insurance Benefits | 2 | 2013 | 183 | 0.160 |
Why?
|
Health Care Costs | 5 | 2020 | 3209 | 0.160 |
Why?
|
Residential Treatment | 1 | 2019 | 111 | 0.160 |
Why?
|
Treatment Outcome | 6 | 2019 | 63114 | 0.150 |
Why?
|
Rural Health Services | 1 | 2021 | 379 | 0.150 |
Why?
|
Longitudinal Studies | 5 | 2023 | 13989 | 0.150 |
Why?
|
Florida | 4 | 2013 | 435 | 0.140 |
Why?
|
Legislation, Medical | 2 | 2022 | 100 | 0.140 |
Why?
|
Hospitals | 2 | 2021 | 3952 | 0.140 |
Why?
|
Health Planning | 3 | 2023 | 238 | 0.140 |
Why?
|
Physicians, Primary Care | 1 | 2023 | 591 | 0.140 |
Why?
|
Mass Screening | 3 | 2019 | 5255 | 0.140 |
Why?
|
Affective Symptoms | 1 | 2019 | 407 | 0.140 |
Why?
|
Depression, Postpartum | 2 | 2011 | 340 | 0.140 |
Why?
|
Cost Sharing | 3 | 2020 | 407 | 0.140 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2019 | 397 | 0.140 |
Why?
|
Health Care Rationing | 2 | 2013 | 437 | 0.130 |
Why?
|
Insurance, Pharmaceutical Services | 1 | 2018 | 336 | 0.130 |
Why?
|
Patient Preference | 2 | 2023 | 890 | 0.130 |
Why?
|
Depression | 4 | 2023 | 7766 | 0.130 |
Why?
|
Health Care Surveys | 3 | 2021 | 2453 | 0.130 |
Why?
|
Federal Government | 2 | 2006 | 260 | 0.120 |
Why?
|
Medically Uninsured | 1 | 2020 | 853 | 0.120 |
Why?
|
Violence | 1 | 2000 | 909 | 0.120 |
Why?
|
Hospitals, General | 1 | 2018 | 749 | 0.120 |
Why?
|
Logistic Models | 4 | 2015 | 13408 | 0.120 |
Why?
|
Decision Making | 3 | 2023 | 3887 | 0.120 |
Why?
|
Risperidone | 1 | 2016 | 383 | 0.110 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2015 | 6038 | 0.110 |
Why?
|
Interviews as Topic | 3 | 2023 | 2539 | 0.110 |
Why?
|
Risk Adjustment | 1 | 2016 | 594 | 0.110 |
Why?
|
Insurance Claim Reporting | 2 | 2018 | 163 | 0.100 |
Why?
|
Urban Population | 1 | 2020 | 2021 | 0.100 |
Why?
|
Health Services Needs and Demand | 2 | 2013 | 1411 | 0.100 |
Why?
|
Interpersonal Relations | 1 | 2019 | 1425 | 0.100 |
Why?
|
Information Dissemination | 2 | 2018 | 1099 | 0.100 |
Why?
|
Hospitalization | 6 | 2022 | 10262 | 0.100 |
Why?
|
Area Under Curve | 1 | 2015 | 1654 | 0.100 |
Why?
|
Patient Discharge | 2 | 2023 | 3313 | 0.100 |
Why?
|
Anxiety Disorders | 1 | 2022 | 2690 | 0.100 |
Why?
|
Drugs, Generic | 1 | 2016 | 421 | 0.100 |
Why?
|
Maryland | 2 | 2021 | 276 | 0.090 |
Why?
|
Aged, 80 and over | 7 | 2022 | 57776 | 0.090 |
Why?
|
Patient-Centered Care | 1 | 2020 | 1439 | 0.090 |
Why?
|
Medicare Part C | 3 | 2022 | 296 | 0.090 |
Why?
|
Needs Assessment | 1 | 2016 | 1147 | 0.090 |
Why?
|
United States Food and Drug Administration | 3 | 2013 | 1584 | 0.090 |
Why?
|
Multicenter Studies as Topic | 1 | 2015 | 1677 | 0.090 |
Why?
|
Alcohol Drinking | 1 | 2022 | 3966 | 0.090 |
Why?
|
Cyclohexanecarboxylic Acids | 1 | 2010 | 141 | 0.080 |
Why?
|
Psychotherapy, Group | 2 | 2021 | 406 | 0.080 |
Why?
|
Primary Health Care | 2 | 2022 | 4558 | 0.080 |
Why?
|
Psychometrics | 2 | 2015 | 3002 | 0.080 |
Why?
|
Patient Satisfaction | 1 | 2021 | 3396 | 0.080 |
Why?
|
Inappropriate Prescribing | 1 | 2011 | 202 | 0.080 |
Why?
|
Off-Label Use | 1 | 2010 | 169 | 0.080 |
Why?
|
Amines | 1 | 2010 | 276 | 0.080 |
Why?
|
Qualitative Research | 3 | 2023 | 2682 | 0.080 |
Why?
|
Self Report | 1 | 2019 | 3558 | 0.080 |
Why?
|
Patents as Topic | 1 | 2009 | 103 | 0.080 |
Why?
|
New York | 1 | 2010 | 886 | 0.080 |
Why?
|
Conflict of Interest | 1 | 2013 | 544 | 0.080 |
Why?
|
Severity of Illness Index | 3 | 2020 | 15540 | 0.080 |
Why?
|
Massachusetts | 1 | 2020 | 8663 | 0.080 |
Why?
|
Anti-Anxiety Agents | 1 | 2010 | 390 | 0.080 |
Why?
|
Social Security | 1 | 2007 | 101 | 0.070 |
Why?
|
Probability | 2 | 2011 | 2505 | 0.070 |
Why?
|
Benzodiazepines | 1 | 2013 | 1101 | 0.070 |
Why?
|
National Health Insurance, United States | 1 | 2007 | 104 | 0.070 |
Why?
|
Neuropsychological Tests | 1 | 2019 | 6993 | 0.070 |
Why?
|
Remission Induction | 1 | 2012 | 2386 | 0.070 |
Why?
|
Motivation | 1 | 2016 | 1971 | 0.070 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2009 | 503 | 0.070 |
Why?
|
Students | 1 | 2015 | 1654 | 0.070 |
Why?
|
Disease Management | 1 | 2016 | 2459 | 0.070 |
Why?
|
Continuity of Patient Care | 2 | 2011 | 1049 | 0.060 |
Why?
|
Reference Standards | 1 | 2009 | 1025 | 0.060 |
Why?
|
Practice Guidelines as Topic | 4 | 2008 | 7279 | 0.060 |
Why?
|
Quality Improvement | 1 | 2020 | 3749 | 0.060 |
Why?
|
Long-Term Care | 1 | 2009 | 607 | 0.060 |
Why?
|
Organizational Policy | 2 | 2013 | 429 | 0.060 |
Why?
|
Psychotic Disorders | 1 | 2019 | 3046 | 0.060 |
Why?
|
Data Collection | 2 | 2006 | 3341 | 0.060 |
Why?
|
Time Factors | 2 | 2020 | 40075 | 0.060 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2010 | 1121 | 0.060 |
Why?
|
Retrospective Studies | 8 | 2023 | 77449 | 0.060 |
Why?
|
Child | 9 | 2023 | 77709 | 0.060 |
Why?
|
Guideline Adherence | 3 | 2014 | 2266 | 0.060 |
Why?
|
Cost of Illness | 1 | 2013 | 1859 | 0.060 |
Why?
|
Sensitivity and Specificity | 2 | 2015 | 14722 | 0.060 |
Why?
|
Family Therapy | 1 | 2004 | 207 | 0.050 |
Why?
|
Computer Simulation | 1 | 2016 | 6196 | 0.050 |
Why?
|
Medical Savings Accounts | 1 | 2022 | 32 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2015 | 12245 | 0.050 |
Why?
|
Cost Control | 1 | 2004 | 624 | 0.050 |
Why?
|
Cross-Sectional Studies | 4 | 2024 | 25043 | 0.050 |
Why?
|
Drug Costs | 1 | 2009 | 1105 | 0.050 |
Why?
|
Reproducibility of Results | 2 | 2015 | 19905 | 0.050 |
Why?
|
Databases, Factual | 1 | 2016 | 7729 | 0.050 |
Why?
|
Child Health Services | 1 | 2007 | 667 | 0.050 |
Why?
|
Emergency Service, Hospital | 4 | 2023 | 7659 | 0.050 |
Why?
|
New Jersey | 2 | 2011 | 290 | 0.050 |
Why?
|
United States Substance Abuse and Mental Health Services Administration | 1 | 2020 | 20 | 0.050 |
Why?
|
Quality Assurance, Health Care | 1 | 2011 | 2212 | 0.050 |
Why?
|
Health Care Reform | 2 | 2012 | 1261 | 0.040 |
Why?
|
Homes for the Aged | 1 | 2022 | 260 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 15076 | 0.040 |
Why?
|
Poverty | 1 | 2011 | 2660 | 0.040 |
Why?
|
United States Department of Veterans Affairs | 1 | 2023 | 875 | 0.040 |
Why?
|
Diagnosis-Related Groups | 1 | 2000 | 455 | 0.040 |
Why?
|
Specialization | 1 | 2024 | 777 | 0.040 |
Why?
|
Combined Modality Therapy | 2 | 2011 | 8642 | 0.040 |
Why?
|
Health Policy | 1 | 2011 | 2661 | 0.040 |
Why?
|
Family Health | 1 | 2022 | 1282 | 0.040 |
Why?
|
Costs and Cost Analysis | 1 | 2023 | 1681 | 0.040 |
Why?
|
Choice Behavior | 1 | 2023 | 803 | 0.040 |
Why?
|
Confidence Intervals | 2 | 2013 | 2971 | 0.040 |
Why?
|
Models, Statistical | 1 | 2012 | 5102 | 0.040 |
Why?
|
Forecasting | 1 | 2006 | 2951 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2009 | 10943 | 0.030 |
Why?
|
Minority Groups | 1 | 2024 | 1223 | 0.030 |
Why?
|
Psychotropic Drugs | 1 | 2022 | 894 | 0.030 |
Why?
|
Private Sector | 1 | 2018 | 392 | 0.030 |
Why?
|
Health Facilities | 1 | 2020 | 573 | 0.030 |
Why?
|
Prognosis | 1 | 2015 | 29063 | 0.030 |
Why?
|
Perception | 1 | 2021 | 1198 | 0.030 |
Why?
|
Chronic Disease | 2 | 2022 | 9146 | 0.030 |
Why?
|
Nursing Homes | 1 | 2022 | 1036 | 0.030 |
Why?
|
Risk Assessment | 1 | 2015 | 23338 | 0.030 |
Why?
|
Mood Disorders | 1 | 2020 | 1106 | 0.030 |
Why?
|
Emergency Services, Psychiatric | 1 | 2013 | 68 | 0.030 |
Why?
|
Factor Analysis, Statistical | 1 | 2015 | 977 | 0.030 |
Why?
|
Anxiety | 1 | 2007 | 4297 | 0.030 |
Why?
|
Internship and Residency | 1 | 2013 | 5788 | 0.030 |
Why?
|
Prospective Studies | 1 | 2015 | 53288 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2000 | 2716 | 0.020 |
Why?
|
Treatment Failure | 1 | 2016 | 2618 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2019 | 5078 | 0.020 |
Why?
|
Utilization Review | 1 | 2011 | 392 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2011 | 39050 | 0.020 |
Why?
|
Marketing of Health Services | 1 | 2010 | 153 | 0.020 |
Why?
|
State Health Plans | 1 | 2011 | 216 | 0.020 |
Why?
|
Observation | 1 | 2010 | 312 | 0.020 |
Why?
|
Wounds and Injuries | 1 | 2000 | 2400 | 0.020 |
Why?
|
Drug Compounding | 1 | 2009 | 242 | 0.020 |
Why?
|
Length of Stay | 1 | 2021 | 6309 | 0.020 |
Why?
|
Drug Utilization Review | 1 | 2009 | 245 | 0.020 |
Why?
|
Hyperlipidemias | 1 | 2013 | 789 | 0.020 |
Why?
|
Models, Organizational | 1 | 2011 | 574 | 0.020 |
Why?
|
Economic Competition | 1 | 2009 | 214 | 0.020 |
Why?
|
Suicidal Ideation | 1 | 2016 | 1248 | 0.020 |
Why?
|
Pain | 1 | 2022 | 4986 | 0.020 |
Why?
|
Drug Industry | 1 | 2013 | 746 | 0.020 |
Why?
|
Cognition | 1 | 2024 | 6770 | 0.020 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2016 | 1209 | 0.020 |
Why?
|
Attitude of Health Personnel | 1 | 2020 | 3843 | 0.020 |
Why?
|
Preventive Health Services | 1 | 2011 | 575 | 0.020 |
Why?
|
Child, Preschool | 2 | 2018 | 41006 | 0.010 |
Why?
|
Linear Models | 1 | 2013 | 5952 | 0.010 |
Why?
|
Regression Analysis | 1 | 2011 | 6459 | 0.010 |
Why?
|
Patient Dropouts | 1 | 2003 | 421 | 0.010 |
Why?
|
Social Adjustment | 1 | 2003 | 631 | 0.010 |
Why?
|
Odds Ratio | 1 | 2011 | 9849 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2010 | 3610 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2013 | 5751 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2013 | 25625 | 0.010 |
Why?
|
Adaptation, Psychological | 1 | 2003 | 2576 | 0.010 |
Why?
|
Infant | 1 | 2013 | 35136 | 0.010 |
Why?
|
Risk Factors | 1 | 2016 | 72290 | 0.010 |
Why?
|